Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Post by Insightful1on Jun 15, 2020 2:44pm
202 Views
Post# 31152338

Mexico press release

Mexico press release MedX again announce an exclusive distribution agreement to a country with a population of 126 million people. The interesting part is both Brazil (population of 320 million) and Mexico show the same major health care issue...melanomas are detected at the later stages where the outcomes are poor and the cost to treat the patient is exorbitant. I would expect MedX will continue to expand into the Latin and South American countries.

The key is their partnership selection. If you look at the copentancy of their Brazilian partner I suspect their Mexican partners have equal capability. That means after regulatory approval ,which is much easier in Mexico we should see a PO rather quickly. I am expecting them to have regulatory approval by end of Q3.

https://stockhouse.com/news/press-releases/2020/06/15/medx-health-signs-exclusive-distribution-agreement-to-launch-siascopy-on


M
edX released its numbers on Friday (they were in line but ( SIAscopy on DermSecure has not shown up and won't to Q2) which would explain some of the selling today. people are forgetting MedX is well funded now and has a large scalable technology. so people worried about the going concern statement should remember MedX just raised over $3.4 million
Bullboard Posts